Published in J Biol Inorg Chem on September 23, 2005
Organometallic anticancer compounds. J Med Chem (2010) 2.19
In situ imaging of metals in cells and tissues. Chem Rev (2009) 2.03
Synchrotron radiation induced X-ray emission studies of the antioxidant mechanism of the organoselenium drug ebselen. J Biol Inorg Chem (2012) 0.82
On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapy. Bioinorg Chem Appl (2012) 0.81
Bioorganometallic Chemistry of Molybdenocene Dichloride and Its Derivatives. J Organomet Chem (2012) 0.77
X-ray fluorescence imaging of single human cancer cells reveals that the N-heterocyclic ligands of iodinated analogues of ruthenium anticancer drugs remain coordinated after cellular uptake. J Biol Inorg Chem (2013) 0.75
Electronic Structure of the d Bent-metallocene Cp(2)VCl(2): A Photoelectron and Density Functional Study. J Organomet Chem (2008) 0.75
Specific Interactions of Antitumor Metallocenes with Deoxydinucleoside Monophosphates. J Am Soc Mass Spectrom (2017) 0.75
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
An improved colorimetric assay for interleukin 2. J Immunol Methods (1986) 3.39
Quantifying trace elements in individual aquatic protist cells with a synchrotron X-ray fluorescence microprobe. Anal Chem (2003) 1.64
Elemental and redox analysis of single bacterial cells by x-ray microbeam analysis. Science (2004) 1.62
Non-platinum chemotherapeutic metallopharmaceuticals. Chem Rev (1999) 1.61
Antitumour metallocenes: structure-activity studies and interactions with biomolecules. Curr Med Chem (2000) 1.48
Titanocene dichloride--the first metallocene with cancerostatic activity. Angew Chem Int Ed Engl (1979) 1.43
Phase II trial of titanocene dichloride in advanced renal-cell carcinoma. Cancer Chemother Pharmacol (1998) 1.36
The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. J Biol Inorg Chem (2003) 1.25
Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer. J Clin Oncol (1998) 1.16
Applications of synchrotron-based X-ray microprobes. Chem Rev (2001) 1.10
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors. Clin Cancer Res (1998) 1.09
Microchemical element imaging of yeast and human cells using synchrotron X-ray microprobe with Kirkpatrick-Baez optics. Anal Chem (2004) 1.01
Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung cells: intracellular mapping of the biotransformation products of a chromium carcinogen. J Biol Inorg Chem (2002) 1.00
Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride. Biochemistry (2000) 0.99
Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride. J Med Chem (2005) 0.87
Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride. J Biol Inorg Chem (2001) 0.85
Organometallic anticancer agents. 2. Aqueous chemistry and interaction of niobocene dichloride with nucleic acid constituents and amino acids. J Med Chem (1996) 0.84
Tumor inhibition by metallocenes: ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy. Chem Biol Interact (1983) 0.81
Inhibition of human topoisomerase II by the antitumor metallocenes. J Inorg Biochem (2001) 0.80
[Molybdocene dichloride as an antitumor agent (author's transl)]. Z Naturforsch C (1979) 0.80
Different inhibition pattern of the nucleic acid metabolism after in vitro treatment with titanocene and vanadocene dichlorides. Naturwissenschaften (1981) 0.78
Study of titanocene-DNA and molybdenocene-DNA interactions by inductively coupled plasma-atomic emission spectroscopy. Anal Bioanal Chem (2004) 0.78
Intracellular distribution of titanium after treatment with the antitumor agent titanocene dichloride: on electron energy loss spectroscopic study. Naturwissenschaften (1981) 0.76
Protein oxidation implicated as the primary determinant of bacterial radioresistance. PLoS Biol (2007) 3.22
c-Type cytochrome-dependent formation of U(IV) nanoparticles by Shewanella oneidensis. PLoS Biol (2006) 2.80
Biology of TiO2-oligonucleotide nanocomposites. Nat Mater (2003) 2.68
Imaging of the intracellular topography of copper with a fluorescent sensor and by synchrotron x-ray fluorescence microscopy. Proc Natl Acad Sci U S A (2005) 2.30
X-ray fluorescence microprobe imaging in biology and medicine. J Cell Biochem (2006) 2.07
Mechanisms of gold biomineralization in the bacterium Cupriavidus metallidurans. Proc Natl Acad Sci U S A (2009) 1.81
High resolution 3D x-ray diffraction microscopy. Phys Rev Lett (2002) 1.63
Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst (2005) 1.63
Elemental and redox analysis of single bacterial cells by x-ray microbeam analysis. Science (2004) 1.62
Migration of mercury from dental amalgam through human teeth. J Synchrotron Radiat (2008) 1.53
Deinococcus geothermalis: the pool of extreme radiation resistance genes shrinks. PLoS One (2007) 1.52
Intracellular distribution of TiO2-DNA oligonucleotide nanoconjugates directed to nucleolus and mitochondria indicates sequence specificity. Nano Lett (2007) 1.43
Design and synthesis of alpha-helical peptides and mimetics. Org Biomol Chem (2007) 1.35
Nanoparticles for applications in cellular imaging. Nanoscale Res Lett (2007) 1.34
The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. J Biol Inorg Chem (2003) 1.25
Labeling TiO2 nanoparticles with dyes for optical fluorescence microscopy and determination of TiO2-DNA nanoconjugate stability. Small (2009) 1.21
A high-performance nanobio photocatalyst for targeted brain cancer therapy. Nano Lett (2009) 1.19
Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc Natl Acad Sci U S A (2006) 1.18
Changes of the phagosomal elemental concentrations by Mycobacterium tuberculosis Mramp. Microbiology (2005) 1.17
Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem Soc Rev (2013) 1.14
Trace metal imaging with high spatial resolution: applications in biomedicine. Metallomics (2010) 1.11
Quantitative X-ray imaging of intraplaque hemorrhage in aortas of apoE(-/-)/LDL(-/-) double knockout mice. Invest Radiol (2007) 1.11
Wilson disease at a single cell level: intracellular copper trafficking activates compartment-specific responses in hepatocytes. J Biol Chem (2010) 1.11
Structures of the cuprous-thiolate clusters of the Mac1 and Ace1 transcriptional activators. Biochemistry (2002) 1.09
Localizing the biochemical transformations of arsenate in a hyperaccumulating fern. Environ Sci Technol (2006) 1.09
Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells. ACS Nano (2013) 1.07
Multiple protective activities of neuroglobin in cultured neuronal cells exposed to hypoxia re-oxygenation injury. J Neurochem (2009) 1.06
Electronic structure description of the cis-MoOS unit in models for molybdenum hydroxylases. J Am Chem Soc (2007) 1.03
Production of Se-methylselenocysteine in transgenic plants expressing selenocysteine methyltransferase. BMC Plant Biol (2004) 1.01
Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung cells: intracellular mapping of the biotransformation products of a chromium carcinogen. J Biol Inorg Chem (2002) 1.00
The role of CAX1 and CAX3 in elemental distribution and abundance in Arabidopsis seed. Plant Physiol (2011) 0.99
Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images. Nanomedicine (2008) 0.99
Metal exposure and Alzheimer's pathogenesis. J Struct Biol (2006) 0.98
The direct mapping of the uptake of platinum anticancer agents in individual human ovarian adenocarcinoma cells using a hard X-ray microprobe. Cancer Res (2003) 0.97
Copper redistribution in Atox1-deficient mouse fibroblast cells. J Biol Inorg Chem (2009) 0.97
Tetrathiomolybdate causes formation of hepatic copper-molybdenum clusters in an animal model of Wilson's disease. J Am Chem Soc (2003) 0.95
Biological applications of X-ray microprobes. Int J Radiat Biol (2009) 0.95
Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury. Chem Res Toxicol (2004) 0.95
The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours. J Struct Biol (2006) 0.94
Observation of an x-ray vortex. Opt Lett (2002) 0.94
Correlative microXRF and optical immunofluorescence microscopy of adherent cells labeled with ultrasmall gold particles. J Struct Biol (2006) 0.94
Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions. J Mol Biol (2006) 0.93
Iron accumulates in Huntington's disease neurons: protection by deferoxamine. PLoS One (2013) 0.93
Silicon nitride as a versatile growth substrate for microspectroscopic imaging and mapping of individual cells. Mol Biosyst (2010) 0.93
Understanding metal homeostasis in primary cultured neurons. Studies using single neuron subcellular and quantitative metallomics. Metallomics (2015) 0.91
Virulence-related Mycobacterium avium subsp hominissuis MAV_2928 gene is associated with vacuole remodeling in macrophages. BMC Microbiol (2010) 0.91
Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives. Dalton Trans (2007) 0.90
Engineering metal-impurity nanodefects for low-cost solar cells. Nat Mater (2005) 0.90
Photoreduction kinetics of sodium tetrachloroaurate under synchrotron soft X-ray exposure. Langmuir (2011) 0.89
Inclusion complexes of the antitumour metallocenes Cp(2)MCl(2) (M = Mo, Ti) with cucurbit[n]urils. Dalton Trans (2008) 0.89
Design and synthesis of antifreeze glycoproteins and mimics. Chembiochem (2010) 0.87
Vascular metallomics: copper in the vasculature. Vasc Med (2009) 0.87
Compartment-specific enhancement of white matter and nerve ex vivo using chromium. Magn Reson Med (2010) 0.87
Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride. J Med Chem (2005) 0.87
Time-dependent uptake, distribution and biotransformation of chromium(VI) in individual and bulk human lung cells: application of synchrotron radiation techniques. J Biol Inorg Chem (2005) 0.87
An iron-dependent and transferrin-mediated cellular uptake pathway for plutonium. Nat Chem Biol (2011) 0.86
Influence of melanosome dynamics on melanoma drug sensitivity. J Natl Cancer Inst (2009) 0.86
Human macrophage ATP7A is localized in the trans-Golgi apparatus, controls intracellular copper levels, and mediates macrophage responses to dermal wounds. Inflammation (2012) 0.86
Plutonium uptake and distribution in mammalian cells: molecular vs. polymeric plutonium. Int J Radiat Biol (2011) 0.85
Applications of type I antifreeze proteins: studies with model membranes & cryoprotectant properties. Curr Protein Pept Sci (2006) 0.85
Redox activity and two-step valence tautomerism in a family of dinuclear cobalt complexes with a spiroconjugated bis(dioxolene) ligand. J Am Chem Soc (2013) 0.84
Does cytotoxicity of metallointercalators correlate with cellular uptake or DNA affinity? Dalton Trans (2012) 0.84
Metabolism of selenite in human lung cancer cells: X-ray absorption and fluorescence studies. J Am Chem Soc (2011) 0.84
Role of biogenic silica in the removal of iron from the Antarctic seas. Nat Commun (2013) 0.84
Localizing the chemical forms of sulfur in vivo using X-ray fluorescence spectroscopic imaging: application to onion (Allium cepa) tissues. Biochemistry (2009) 0.84
β-Cell subcellular localization of glucose-stimulated Mn uptake by X-ray fluorescence microscopy: implications for pancreatic MRI. Contrast Media Mol Imaging (2011) 0.84
Uptake, distribution, and speciation of selenoamino acids by human cancer cells: X-ray absorption and fluorescence methods. Biochemistry (2011) 0.84
A two-step valence tautomeric transition in a dinuclear cobalt complex. Inorg Chem (2012) 0.84
Influence of Atmospheric Processes on the Solubility and Composition of Iron in Saharan Dust. Environ Sci Technol (2016) 0.83
Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper-indomethacin in rats. Cancer Chemother Pharmacol (2009) 0.83
The effect of metal ions on the electrochemistry of the antitumor antibiotic streptonigrin. J Inorg Biochem (2004) 0.83
N,N-diethyldithiocarbamate promotes oxidative stress prior to myelin structural changes and increases myelin copper content. Toxicol Appl Pharmacol (2009) 0.83
The endothelium-derived hyperpolarizing factor, H2O2, promotes metal-ion efflux in aortic endothelial cells: elemental mapping by a hard X-ray microprobe. Biochemistry (2006) 0.83
Solution structure of a hydrophobic analogue of the winter flounder antifreeze protein. Eur J Biochem (2002) 0.83
Aging results in copper accumulations in glial fibrillary acidic protein-positive cells in the subventricular zone. Aging Cell (2013) 0.83
Subcellular redistribution and mitotic inheritance of transition metals in proliferating mouse fibroblast cells. Metallomics (2013) 0.82
The sulfur chemistry of shiitake mushroom. J Am Chem Soc (2004) 0.82
Synchrotron radiation X-ray fluorescence microscopy reveals a spatial association of copper on elastic laminae in rat aortic media. Metallomics (2011) 0.82
Synchrotron radiation induced X-ray emission studies of the antioxidant mechanism of the organoselenium drug ebselen. J Biol Inorg Chem (2012) 0.82
Solution structure of a recombinant type I sculpin antifreeze protein. Biochemistry (2005) 0.82